407 results on '"Joles JA"'
Search Results
2. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction
3. Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease
4. Developmental programming in human umbilical cord vein endothelial cells following fetal growth restriction
5. Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease
6. Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction : A Focus on Microcirculatory Factors and Therapeutic Targets
7. Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
8. Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease
9. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction
10. Electrifying solutions for a miniature dialysis device
11. Life after placental dysfunction : the mother's renal function and her child's health
12. Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening
13. The importance of intake : a gut feeling
14. Renal and cardiac microvascular endothelium: injury and repair
15. Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease
16. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
17. Rapid hepatic clearance of full length CCN-2/CTGF: a putative role for LRP1-mediated endocytosis
18. Reprogramming : A Preventive Strategy in Hypertension Focusing on the Kidney
19. Reprogramming: A Preventive Strategy in Hypertension Focusing on the Kidney
20. The importance of intake: a gut feeling
21. Cell-based therapies for chronic kidney disease
22. Pharmacokinetics of connective tissue growth factor : implications for its use as biomarker
23. Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients
24. The Severe Cardiorenal Syndrome
25. Obesity in dogs: effects on renal function, blood pressure, and renal disease
26. Efficacy and muscle safety of fluvastatin in cyclosporine-treated cardiac and renal transplant recipients
27. Ovariectomy decreases plasma triglyceride levels and both prevents and alleviates glomerular disease in uninephrectomized female analbuminemic rats
28. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats
29. Renal Apolipoproteins in Nephrotic Rats
30. Dietary sucrose does not increase twenty-four-hour ambulatory blood pressure in patients with either essential hypertension or polycystic kidney disease
31. Atorvastatin reduces sympathetic activity in patients with chronic kidney disease.
32. Hyperlipoproteinemia in Nagase analbuminemic rats: effects of pravastatin on plasma (apo)lipoproteins and lecithin:cholesterol acyltransferase activity.
33. Effects of NaHCO3, α- and β-Adrenergic Blockade on Albuminuria after Swimming in Splenectomized Dogs
34. Expanding the beneficial pleiotropic repertoire of interleukin-10.
35. PLASMA-LIPOPROTEIN COMPOSITION AND GLOMERULAR APOLIPOPROTEIN AND LIPID DISTRIBUTION IN RATS WITH CHRONIC NEPHROTIC SYNDROME INDUCED BY A SINGLE LOW-DOSE OF ADRIAMYCIN
36. PROTEINURIA AND GLOMERULAR APOLIPOPROTEIN (APO) DEPOSITION IN UNINEPHRECTOMIZED FEMALE ANALBUMINEMIC RATS
37. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein (LDL)
38. ALPHA-2-MACROGLOBULIN (ALPHA-2M) AND TRANSFORMING GROWTH-FACTOR (TGF)-BETA IN NEPHROTIC RATS
39. Albumin reverses lysophosphatidylcholine-induced inhibition of endothelium-dependent vasodilation
40. HMG COA REDUCTASE INHIBITION DECREASES LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) AND TRIGLYCERIDES (TG) IN FEMALE ANALBUMINEMIC RATS
41. PLASMA-LIPOPROTEIN COMPOSITION AND GLOMERULAR APOLIPOPROTEIN AND LIPID DISTRIBUTION IN RATS WITH CHRONIC NEPHROTIC SYNDROME INDUCED BY A SINGLE LOW-DOSE OF ADRIAMYCIN
42. PLASMA-LIPOPROTEINS AND RENAL APOLIPOPROTEINS IN RATS WITH CHRONIC ADRIAMYCIN NEPHROSIS
43. APOLIPOPROTEINS IN EXPERIMENTAL NEPHROTIC SYNDROME
44. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
45. EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPEMIA OF NEPHROTIC SYNDROME
46. Role of nitric oxide in renal vascular resistance in SHR before and after uninephrectomy
47. The endothelin system is involved in the effects of chronic NOS inhibition
48. Endothelin a receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition
49. INCREASED EXPRESSION OF A NOVEL CONNECTIVE-TISSUE GROWTH-FACTOR AFTER UNINEPHRECTOMY (UNIX) IN SPONTANEOUS HYPERTENSIVE RATS (SHR)
50. Albumin reverses lysophosphatidylcholine-induced inhibition of endothelium-dependent vasodilation in rat aortic rings
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.